Airway Management During Deep Sedation in Hysteroscopy

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05701839
Collaborator
(none)
400
1
4
21.9
18.2

Study Details

Study Description

Brief Summary

Hysteroscopy is used to examine and treat uterine diseases. Because of severe pain due to uterine distention and cervical dilatation, deep sedation usually be provided during this procedure. Respiratory depression and upper airway obstruction are main respiratory complications during deep sedation. Face mask and nasopharyngeal airway are main airway management during deep sedation. Oxygen reserve index is a non-invasive parameter, it reflects the moderate hyperoxia statues. In this study, investigators compare the effect of face mask and nasopharyngeal airway management on oxygenation during deep sedation in participants undergoing hysteroscopy. Investigators also investigate whether oxygen reserve index monitoring reduce the incidence of hypoxemia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: face mask ventilation
  • Procedure: nasopharyngeal tube ventilation
  • Device: oxygen saturation monitoring
  • Device: oxygen reserve index monitoring
N/A

Detailed Description

Randomization:

Participants are divided into four groups: face mask airway management without oxygen reserve index (ORi) monitoring group (FM-ORi group), face mask airway management with ORi monitoring group (FM+ORi group), nasopharyngeal tube airway management without ORi monitoring group (NT-ORi group), nasopharyngeal tube with ORi monitoring group (NT+ORi group).

Deep sedation process:

Participants fasting solid and liquid for 8 and 4 hours respectively. Electrocardiogram (ECG), oxygen saturation (SpO2), blood pressure (BP) and bispectral index (BIS) were monitored. Sufentanil 5 μg injected for 30 seconds, followed by target-control infusion of propofol (plasma target concentration 3-6 ug/ml) to maintain BIS between 50-70. Criteria for deep sedation: participants have purposeful response after repeated and/or painful stimulation, there is minimal effect on hemodynamic stability.

Airway management:

In FM-ORi and FM+ORi group, participants spontaneous inhaled oxygen through face mask at a flow rate of 5 L/min. in FM-ORi group, assist ventilation through face mask was performed when SpO2 dropped to 95%, it lasted for another 10 seconds when SpO2 restored to 100%. In FM+ORi group, assist ventilation through face mask was performed when ORi dropped to 0.1, it lasted for another 10 seconds when ORi restored to 0.1.

In NT-ORi and NT+ORi group, participants spontaneous inhaled oxygen through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min. in NT-ORi group, assist ventilation through face mask was performed when SpO2 dropped to 95%, it lasted for another 10 seconds when SpO2 restored to 100%. In NT+ORi group, assist ventilation through face mask was performed when ORi dropped to 0.1, it lasted for another 10 seconds when ORI restored to 0.1.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Two Different Airway Management on Oxygenation During Deep Sedation in Patients Undergoing Hysteroscopy, Based on Oxygen Reserve Index Monitoring
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Nov 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: face mask airway management without oxygen reserve index monitoring

Participants inhale oxygen through face mask at a flow rate of 5 L/min and will be monitored with oxygen saturation.

Procedure: face mask ventilation
In participants with face mask ventilation, oxygen inhaled through face mask at a flow rate of 5 L/min.

Device: oxygen saturation monitoring
In participants with oxygen saturation monitoring, assist ventilation through face mask will be performed when oxygen saturation drops to 95%, it lasts for another 10 seconds when oxygen saturation restores to 100%.

Experimental: face mask airway management with oxygen reserve index monitoring

Participants inhale oxygen through face mask at a flow rate of 5 L/min and will be monitored with oxygen reserve index.

Procedure: face mask ventilation
In participants with face mask ventilation, oxygen inhaled through face mask at a flow rate of 5 L/min.

Device: oxygen reserve index monitoring
In participants with oxygen reserve index monitoring, assist ventilation through face mask will be performed when oxygen reserve index drops to 0.1, it lasts for another 10 seconds when oxygen reserve index restores to 0.1.

Experimental: nasopharyngeal tube airway management without oxygen reserve index monitoring

Participants inhale oxygen through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min and will be monitored with oxygen saturation.

Procedure: nasopharyngeal tube ventilation
In participants with nasopharyngeal tube ventilation, oxygen inhaled through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min.

Device: oxygen saturation monitoring
In participants with oxygen saturation monitoring, assist ventilation through face mask will be performed when oxygen saturation drops to 95%, it lasts for another 10 seconds when oxygen saturation restores to 100%.

Experimental: nasopharyngeal tube airway management with oxygen reserve index monitoring

Participants inhale oxygen through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min and will be monitored with oxygen reserve index.

Procedure: nasopharyngeal tube ventilation
In participants with nasopharyngeal tube ventilation, oxygen inhaled through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min.

Device: oxygen reserve index monitoring
In participants with oxygen reserve index monitoring, assist ventilation through face mask will be performed when oxygen reserve index drops to 0.1, it lasts for another 10 seconds when oxygen reserve index restores to 0.1.

Outcome Measures

Primary Outcome Measures

  1. The incidence of low oxygen saturation [Procedure (from anesthesia induction to anesthesia recovery)]

    oxygen saturation less than 95% last for at least 10 seconds

Secondary Outcome Measures

  1. Total duration of assist ventilation [Procedure (from anesthesia induction to anesthesia recovery)]

    cumulative assist ventilation time during sedation in one patient

  2. The lowest oxygen saturation [Procedure (from anesthesia induction to anesthesia recovery)]

    the lowest oxygen saturation during sedation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female, 18-60 years old

  • Scheduled for hysteroscopy

  • Predict operation duration more than 10 minutes

Exclusion Criteria:
  • Participants refuse

  • Predict the presence of difficult airway

  • Combined with obstructive sleep apnea syndrome

  • Combined with upper respiratory tract infection, and/or pulmonary inflammation

  • Combined with chronic obstructive pulmonary disease

  • Combined with asthma

  • Body mass index (BMI) >30 kg/m2

  • Coagulation dysfunction, and/or undergo anticoagulant therapy

  • Nasal deformity

  • Pregnancy, positive urine pregnancy test

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi China 710061

Sponsors and Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

Investigators

  • Study Chair: Zheng Guan, MD, First Affiliated Hospital Xi'an Jiaotong University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
First Affiliated Hospital Xi'an Jiaotong University
ClinicalTrials.gov Identifier:
NCT05701839
Other Study ID Numbers:
  • XJTU1AF2022LSK-402
First Posted:
Jan 27, 2023
Last Update Posted:
Feb 1, 2023
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 1, 2023